ENTBF (Entheon Biomedical) Other Long Term Assets: $0.00 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Entheon Biomedical Other Long Term Assets?

Entheon Biomedical ENTBF Other Long Term Assets is $0.00 Mil as of May. 2026.

Entheon Biomedical's other long-term assets for the quarter that ended in May. 2026 was $0.00 Mil.

Entheon Biomedical's quarterly other long-term assets stayed the same from Nov. 2025 ($0.00 Mil) to Feb. 2026 ($0.00 Mil) and stayed the same from Feb. 2026 ($0.00 Mil) to May. 2026 ($0.00 Mil).

Entheon Biomedical's annual other long-term assets declined from Nov. 2023 ($0.00 Mil) to Nov. 2024 ($0.00 Mil) but then increased from Nov. 2024 ($0.00 Mil) to Nov. 2025 ($0.00 Mil).

Entheon Biomedical Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Other Long Term Assets Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 0.00 0.02 0.00 0.00 0.00

Entheon Biomedical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Entheon Biomedical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $0.00 Mil mean?
Entheon Biomedical (ENTBF) has a Other Long Term Assets of $0.00 Mil as of May. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's Other Long Term Assets too high?
Entheon Biomedical's current Other Long Term Assets is $0.00 Mil.
How does Entheon Biomedical's Other Long Term Assets compare to VRTX and REGN?
Entheon Biomedical's Other Long Term Assets of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Biotechnology company?
A good Other Long Term Assets depends on the Biotechnology industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current Other Long Term Assets is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Other Long Term Assets of $0.00 Mil. The current Other Long Term Assets is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Other Long Term Assets is $0.00 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.